STOCK TITAN

Butterfly Network to Present at the 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Butterfly Network, Inc. (NYSE: BFLY) will participate in the 40th Annual J.P. Morgan Healthcare Conference virtually from January 10-13, 2022. Dr. Todd Fruchterman, the President and CEO, will present on January 11, 2022, at 2:15 PM ET. A live webcast and archived recording will be accessible on the Butterfly investor website. Butterfly Network, founded in 2011, is known for its innovative handheld ultrasound technology aimed at improving global health equity, providing ultrasound access to 4.7 billion people worldwide.

Positive
  • None.
Negative
  • None.

GUILFORD, Conn. & NEW YORK--(BUSINESS WIRE)-- Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), today announced that it will participate in the 40th Annual J.P. Morgan Healthcare Conference to be held virtually on January 10-13, 2022. Dr. Todd Fruchterman, President and CEO will present virtually on Tuesday, January 11, 2022, at 2:15 pm Eastern Time.

A live webcast of the presentation and an archived recording will be available in the Events & Presentations section of the Butterfly Network investor website.

About Butterfly Network, Inc.
Founded by Dr. Jonathan Rothberg in 2011, Butterfly Network has created the world’s first handheld, single-probe whole-body ultrasound system using its patented Ultrasound-on-Chip™ semiconductor technology. Butterfly’s mission is to democratize medical imaging and contribute to the aspiration of global health equity, including for the 4.7 billion people around the world lacking access to ultrasound. Butterfly is paving the way for earlier detection and remote management of health conditions around the world. The Butterfly iQ+ and Butterfly iQ+ Vet can be purchased today by healthcare practitioners and veterinarians, respectively, in the United States, Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, New Zealand, Norway, Poland, Portugal, Spain, Sweden, Switzerland, and the United Kingdom. Butterfly iQ+ is a prescription device intended for qualified healthcare professionals only. For more information, visit www.butterflynetwork.com.

Investors

Agnes Lee

650-677-9138

alee@butterflynetwork.com

Media

Holly Spring

media@butterflynetwork.com

Source: Butterfly Network, Inc.

FAQ

When will Butterfly Network present at the J.P. Morgan Healthcare Conference?

Butterfly Network's presentation will take place on January 11, 2022, at 2:15 PM ET.

Where can I watch the Butterfly Network presentation?

The presentation can be viewed live and as an archived recording on the Butterfly investor website.

What is the mission of Butterfly Network?

Butterfly Network aims to democratize medical imaging and improve health equity for those lacking access to ultrasound.

What technology does Butterfly Network use?

Butterfly Network has developed a handheld, single-probe whole-body ultrasound system utilizing patented Ultrasound-on-Chip™ technology.

Which countries have access to Butterfly's ultrasound devices?

Butterfly's devices are available in the United States, Australia, Canada, and several European countries.

Butterfly Network, Inc.

NYSE:BFLY

BFLY Rankings

BFLY Latest News

BFLY Stock Data

662.62M
155.82M
16.79%
27.56%
5.96%
Medical Devices
X-ray Apparatus & Tubes & Related Irradiation Apparatus
Link
United States of America
BURLINGTON